High adherence to secukinumab in patients with moderate to severe psoriasis: a long-term multicenter study in a daily practice setting
Int J Dermatol. 2022 Jul 22. doi: 10.1111/ijd.16365. Online ahead of print.
NO ABSTRACT
PMID:35867958 | DOI:10.1111/ijd.16365